Shares of Procter & Gamble jumped 5% to $147.88 as investors piled into the consumer-staples titan following its fiscal third-quarter 2026 results and reaffirmed full-year outlook, turning P&G into a rare bright spot against a weakening broader market.
• Volume Growth Returned for the First Time in a Year, and That Changes the Story. P&G's volume increased 2%, marking the first time in a year that it reported growing volume across the company. That matters because volume — units actually sold — is a purer measure of demand than revenue, which can be inflated by price hikes. All 10 product categories and all 7 regions grew organic sales for the quarter, signaling that the turnaround is broad-based rather than concentrated in a single brand or geography.
• The Numbers Beat Expectations, but Margins Are Quietly Shrinking. Net sales reached $21.2 billion, up 7%, while organic sales grew 3%; diluted EPS increased 6% to $1.63, and core EPS rose 3% to $1.59.
Analysts had projected earnings of $1.56 per share and revenue of $20.5 billion. Yet underneath the beat, gross margin declined from 51.0% to 49.5% and operating margin fell from 23.0% to 21.5%, pressured by tariffs and commodity costs. The company estimates tariffs alone will cost about $400 million after tax in fiscal 2026.
• The Dividend Streak Keeps Investors Loyal — 70 Years and Counting. P&G lifted its dividend another 3%, marking 70 consecutive years of dividend raises.
The new annualized payout of $4.23 per share results in a yield of roughly 2.88%. In an environment where the S&P 500 trades at lofty valuations, that dependable cash return makes P&G a haven. P&G's price-to-earnings ratio has fallen from 25 to 21 over the past year — below its 10-year median P/E of 25 — making the stock look relatively cheaper than its own history.
• Full-Year Guidance Holds, but Management Signals Caution. P&G expects fiscal 2026 EPS to land toward the lower end of its guidance range of flat to 4% growth, while organic sales guidance of 0–4% also stays in place. P&G will not provide a fiscal 2027 forecast until July; CFO Andre Schulten conceded, "What do we know what the world looks like three months from now?" That honesty underscores real risks — geopolitical disruption, tariff escalation, and softness in China — that could cap upside. Analysts maintain a consensus "Buy" rating with an average 12-month price target of $163.77, implying about 11% further upside from today's rally price. For now, P&G is delivering exactly what nervous investors want: steady results in an unsteady world.